Schubert & CO Repligen Corp Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$162.42 - $220.56 $649 - $882	-4 Reduced 23.53%	13 $2,000
Q3 2022 Oct 21, 2022	BUY	$160.42 - $256.21 $802 - $1,281	5 Added 41.67%	17 $3,000
Q2 2022 Aug 01, 2022	BUY	$140.68 - $188.02 $844 - $1,128	6 Added 100.0%	12 $2,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $161 - $257	1 Added 20.0%	6 $1,000
Q4 2021 Jan 28, 2022	BUY	$247.59 - $304.47 $1,237 - $1,522	5 New	5 $1,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.